Innovus Pharmaceuticals has filed a Product License Application with Health Canada to market its premature ejaculation topical treatment EjectDelay. EjectDelay has the active drug Benzocaine and works by blocking the sodium channels of the nerves and therefore temporarily desensitizing the glans of the penis allowing longer ejaculatory time. If accepted by Health Canada, EjectDelay will be available as a 7.5% strength in a two-ounce over-the-counter gel and will not require a prescription. The ...